Alkermes Receives Moderate Buy Rating and Insiders Sell Stock
Alkermes plc (NASDAQ:ALKS), a biopharmaceutical company specializing in the development and commercialization of innovative medicines, has received a "Moderate Buy" ...
Tag: ALKS
Artisan Partners Limited Partnership Cuts Holdings in Alkermes Plc, While Director Nancy Wysenski Sells Shares
Alkermes Plc has been making waves in the pharmaceutical industry with its innovative medicines designed to address unmet medical needs ...
Alkermes plc Rated as Moderate Buy by Analysts for its Strong CNS Drug Development Portfolio and Robust Performances Amid Covid-19 Disruptions
As the world steadily moves towards progress with technological advancements, the stock market continues to be a powerful tool for ...
Sugarhill Ddot’s Net Worth: Inside The Career of the Rising Drill Rap Star
When it comes to the hip-hop scene in America, there are a few names that stand out. However, one name...
Read more
